Form 4: Pediatrix Director Receives Equity Grant

Director Laura A. Linynsky was granted 7,196 restricted shares of Pediatrix Medical Group, Inc. common stock.

Summary

• Director Laura A. Linynsky acquired 7,196 shares of common stock in Pediatrix Medical Group, Inc. (MD).
• The shares were granted as part of an annual equity award under the company's 2008 Incentive Compensation Plan.
• The transaction occurred on May 7, 2026, at a price of $0 per share.
• Following this transaction, the director's total beneficial ownership increased to 39,428 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Standard annual equity grant indicates routine governance practices.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

The granted shares are subject to a one-year vesting period, becoming fully vested on May 7, 2027.

Industry Context

StockSavvy.ai notes that annual equity grants to board members are a standard corporate governance practice in the healthcare services sector to ensure long-term alignment between leadership and shareholder value.

Comparison to Industry Standards

• The grant follows standard industry practices for non-employee director compensation.
• The use of restricted stock units or restricted shares is consistent with peer companies in the medical services industry.

Stakeholder Impact

• Increased alignment between the director and shareholders.

Next Steps

• Vesting of the 7,196 restricted shares on May 7, 2027.

Key Dates

Keywords

Pediatrix Medical Group, MD, Form 4, Insider Trading, Equity Compensation, Director Ownership